Latest news with #AnshulJain
Mint
a day ago
- Business
- Mint
Brainbees Solutions share price: This new-age stock gains over 20% in one month. Will the momentum continue?
Shares of Brainbees Solutions, the parent company of FirstCry, surged by almost 12% during Thursday's trading session. Despite experiencing volatility, Brainbees Solutions managed to hold its ground following the announcement of its Q4 results. The company reported a net loss of ₹ 111 crore for Q4FY25, which is an increase from the loss of ₹ 43 crore in the same period last year. Revenue from operations grew by 16% year-on-year, reaching ₹ 1,930 crore, compared to ₹ 1,667 crore in Q4FY24. Brainbees Solutions share price today opened at ₹ 366.85 apiece on the BSE, the stock touched an intraday high of ₹ 410 per share and an intraday low of ₹ 359.25. FirstCry share price has gained over 20% in one month. Technical analysts said that FirstCry share price is a newly listed stock so technical data is not available. However with limited data analysts are witnessing a small range breakout with increase in volumes, the positive momentum can extend towards ₹ 450 whereas ₹ 340 is support. Anshul Jain, Head of Research at Lakshmishree Investments explained that FirstCry share price has broken out of a 44-day rounding bottom pattern with strong volumes, registering over 400% of the 50-day average volume at the breakout level of ₹ 394. According to Jain, a sustained move above the psychological resistance of ₹ 400 will likely trigger fresh bullish momentum, pushing the stock towards the ₹ 480 zone. The strong volume surge confirms institutional interest, making the current setup attractive for momentum traders aiming for further upside. JM Financial, a brokerage firm, has reaffirmed a 'buy' recommendation on the stock with a price target of ₹ 488. The report indicated that in Q4FY25, FirstCry achieved a 13.5% year-over-year growth in GMV for its core India Multi-Channel business, which was affected by a slowdown in offline sales and an unusually late winter, while the International segment saw a GMV increase of 16.4%. GlobalBees recorded impressive revenue growth of 33.4% year-over-year. The consolidated gross margin improved to 37.5%, reflecting a decline of 50 basis points year-over-year and quarter-over-quarter. Moreover, the adjusted EBITDA margin expansion for the India multi-channel business was modest at 40 basis points year-over-year due to reduced operating leverage. The consolidated adjusted EBITDA margin rose by 20 basis points year-over-year (a decrease of 120 basis points quarter-over-quarter) to reach 5.2%, largely due to the increasing contribution of the lower-margin GlobalBees segment in the overall revenue mix. 'We believe the company retains its deeply-moated position in its category and will be a key beneficiary of tax benefits and any recovery in discretionary spends. Sustained compounding story with cheap valuations,' the brokerage said. Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.
Mint
2 days ago
- Business
- Mint
SPARC share price tumbles 20% as Sun Pharma's arm halts development of Psoriasis drug
SPARC share price: Shares of Sun Pharma Advanced Research Company (SPARC), the research division of India's top pharmaceutical firm Sun Pharma, fell by 20% on Wednesday after unsatisfactory results from Phase 2 trials of its experimental drug SCD-044. SPARC share price opened at an intraday high of ₹ 186 apiece on the BSE, the stock touched an intraday low of ₹ 156.50 per share. SCD-044, referred to as Vibozilimod, was being developed for the treatment of psoriasis and atopic dermatitis. Nevertheless, the company announced that the drug did not achieve the primary endpoints in both of its clinical trials. Consequently, SPARC declared that it will halt further clinical development for SCD-044. Both Sun Pharma and SPARC will now evaluate the future direction of this compound. This development represents a setback, as SCD-044 was viewed as one of the more promising candidates in SPARC's specialty pipeline. In a filing with the exchange, the company noted that neither the SOLARES PsO trial nor the SOLARES AD trial achieved their primary endpoints—defined as a 75 percent reduction in PASI (Psoriasis Area and Severity Index) or EASI (Eczema Area and Severity Index) scores by Week 16. SPARC, a biopharmaceutical subsidiary of Sun Pharma that focuses on research, aims to drive innovation in fields such as oncology, neurodegenerative diseases, and inflammatory disorders. In the fourth quarter of fiscal year 2025 (Q4FY25), SPARC announced a total income of ₹ 20.96 crore, marking a 38.8% increase from ₹ 15.10 crore in the third quarter (Q3FY25). However, the loss before tax increased to ₹ 105.41 crore compared to ₹ 79.44 crore in the prior quarter, indicating a 32.7% decline in profitability. The total expenses for the quarter rose by 33.7%, reaching ₹ 126.37 crore, up from ₹ 94.54 crore in Q3. Anshul Jain, Head of Research at Lakshmishree Investments, SPARC share price has gapped down, breaching its rising moving averages, indicating a clear structure shift from bullish to bearish. After a sharp 76.88% correction in 47 weeks, the stock was attempting to form a higher low on the weekly chart, which now appears to have failed following the negative clinical trial news. With sentiment turning weak, immediate support is placed at ₹ 128. A breach of this support may accelerate further downside in the short term. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
3 days ago
- Business
- Mint
Rafale brand owner Dassault Aviation share price jumps 5% in five days. Experts see fresh momentum ahead
Rafale brand owner Dassault Aviation share price has rallied over 5.08 per cent in past five trading session on the Paris Stock Exchange. The Rafale jet manufacturer has remained volatile lately, falling over 2.30 per cent in a month. On June 2, Dassault Aviation stock closed at €322.40 apiece, only 3 per cent away from hitting 52-week high of €332.20. Dassault Aviation stock grabbed investor's attention after the Indian Air Force's Operation Sindoor on May 7, 2025. Initially, the stock saw a significant surge up to 66 per cent after the Indo-Pak tensions escalated in May, however, has given up the gains. The Rafale jet manufacturer's stock has attracted significant attention following India's launch of Operation Sindoor—a strategic airstrike targeting terrorist camps situated 200 kilometers within Pakistani territory and Pakistan-occupied Kashmir, while deliberately steering clear of breaching Pakistani airspace. According to multiple reports, the Indian Air Force carried out the mission using Rafale fighter jets armed with SCALP cruise missiles and HAMMER precision-guided bombs. According to market experts, Dassault Aviation's stock is on the verge of a bullish breakout from a 50-day-long cup and handle pattern, with the breakout pivot placed at ₹ 324. Anshul Jain, Head of Research at Lakshmishree Investments, believes that a high-volume breakout above €324 will confirm the pattern and likely trigger fresh bullish momentum. 'Dassault Aviation is on the verge of a bullish breakout from a 50-day-long cup and handle pattern, with the breakout pivot placed at €324. Volumes in the base have been accumulative, indicating strong institutional interest. A high-volume breakout above €324 will confirm the pattern and likely trigger fresh bullish momentum. Post-breakout, the stock is expected to head towards an immediate upside target of €375, supported by its strong price structure and accumulation,' Jain said. Meanwhile, Riyank Arora, Technical Analyst at Mehta Equities Ltd, says that a sustained move above €332 with volume confirmation may attract fresh buying interest. 'Dassault Aviation is trading near a key resistance at €332. A decisive breakout above this level could open the path toward the next resistance zone at €350-360. On the downside, immediate support is placed at €310, and if breached, the stock may slip toward the next support at €300. The overall trend remains mildly positive,' Arora said. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
4 days ago
- Business
- Mint
Reliance Power share price jumps 8% to fresh 52-week high; Should you buy?
Reliance Power share price extended its upward momentum for the third consecutive session on Monday, surging nearly 8% to hit a fresh 52-week high amid robust trading volumes. The Anil Ambani-led Reliance Power shares rallied as much as 7.79% to touch a new high of ₹ 62.80 apiece on the BSE. This latest gain in Reliance Power shares follows an impressive 11% jump in the previous session, bringing the stock's one-week gain to over 21%. Trading volumes in Reliance Power shares were significantly elevated, with around 61 crore shares changing hands on Monday — more than double its one-week average of 27 crore shares, and nearly five times the one-month average of 13 crore shares. The surge in trading activity and stock price follows the announcement of a major renewable energy project win. Reliance Power on May 28 announced that its subsidiary, Reliance NU Energies Private Limited (Reliance NU Energies), received the Letter of Award (LOA) from SJVN, a Navratna Central Public Sector Enterprise, for a 350 MW inter-state transmission system (ISTS)-connected solar power project coupled with a 175 MW/700 MWh Battery Energy Storage System (BESS). Once commissioned, the platform will add 600 MW of solar DC capacity, and 700 MWh of BESS capacity to Reliance Power's portfolio. The company's total clean energy pipeline now stands at 2.4 GW of Solar DC capacity and over 2.5 GWH of BESS capacity, making it India's largest player in the integrated Solar + BESS segment, Reliance Power said in a regulatory filing on May 28, 2025. Reliance NU Energies had earlier emerged as the successful bidder in the competitive auction conducted by SJVN, securing the project at a fixed tariff of ₹ 3.33 per kWh for a period of 25 years. Reliance Power share price has delivered stellar returns in recent months. The Anil Ambani Group stock is up 53% over the past one month and 85% over the last three months. On a year-to-date (YTD) basis, Reliance Power shares have gained 38%, while delivering multibagger returns of 151% over the past one year. The rally has been even more pronounced over the long term, with the Reliance Power stock price rising 370% in two years and an astounding 2,800% over the last five years. From a technical perspective, Reliance Power is currently the strongest performer among Anil Dhirubhai Ambani Group (ADAG) stocks. The stock recently broke out of a 33-week-long 'cup and handle' formation on the weekly chart, noted Anshul Jain, Head of Research at Lakshmishree Investments. 'The breakout was backed by volumes 8x higher than the 50-day average, indicating strong, broad-based participation. Reliance Power share price is currently holding above the breakout level, and any dip towards ₹ 48 or consolidation around this zone presents a fresh buying opportunity,' Jain said. The pattern projects an immediate upside target of ₹ 65, with a further potential move towards ₹ 79, he added. At 12:40 PM, Reliance Power share price was trading 6.52% higher at ₹ 61.95 apiece on the BSE. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
30-05-2025
- Business
- Mint
MMTC share price surges over 50% in May; is it still a stock to buy?
MMTC share price continued witnessing strong buying interest for the third consecutive session on Friday, May 30, rising over 8 per cent in morning trade on the BSE. MMTC share price opened at ₹ 84.21 against its previous close of ₹ 81.36 and surged 8.4 per cent to an intraday high of ₹ 88.20. At this price, the stock has jumped 38 per cent in three sessions and 57 per cent in May after an 8 per cent gain in April and a 6 per cent gain in March. MMTC share price hit a 52-week low of ₹ 42.55 on April 7 this year and a 52-week high of ₹ 131.88 on July 26 last year. MMTC on May 29 reported a 96.8 per cent year-on-year plunge in its consolidated net profit for Q4FY25 to ₹ 2.23 crore, compared to ₹ 69.78 crore in the same quarter last year. Total income dropped 32 per cent YoY to ₹ 44.14 crore in Q4FY25 from ₹ 64.98 crore in Q4FY24. The stock's sharp gains since March have stretched its valuations. Its current trailing twelve-month price-to-earnings (PE) ratio, near 150, is high in the industry. The stock looks overbought, and technical charts indicate the possibility of a profit booking. Anshul Jain, the head of research at Lakshmishree Investments, highlighted that MMTC stock broke out of a cup and handle pattern at ₹ 63 and rallied sharply, testing the 50 per cent retracement level of its 66.25 per cent fall over 37 weeks, placed at ₹ 86. "The rally has been steep and vertical, indicating that profit booking at current levels is highly likely. Traders are advised to book profits and wait for a fresh accumulation or consolidation pattern to develop before considering new long positions for the next leg," said Jain. Read all market-related news here Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.
